Skip to Content

Exenatide

In the US, Exenatide (exenatide systemic) is a member of the drug class incretin mimetics and is used to treat Diabetes, Type 2.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BJ01

CAS registry number (Chemical Abstracts Service)

0141758-74-9

Chemical Formula

C184-H282-N50-O60-S

Molecular Weight

4186

Therapeutic Category

Antidiabetic agent: Incretin-mimetic, glucagon-like peptide-1 (GLP-1) agonist

Chemical Names

Exendin 4 (USAN)

L-Histidylglycyl-L-glutamylglycyl-L-treonyl-L-phenylalanyl-L-treonyl-L-seryl-L-aspartyl-L-leucyl-L-seryl-L-lysyl-L-glutaminyl-L-metionyl-L-glutamyl-L-glutamyl-L-glutamyl-L-alanyl-L-valyl-L-arginyl-L-leucyl-L-phenylalanyl-L-isoleucyl-L-glutamyl-L-tryptophy (WHO)

Foreign Names

  • Exenatidum (Latin)
  • Exenatid (German)
  • ExĂ©natide (French)
  • Exenatida (Spanish)

Generic Names

  • Exenatide (OS: USAN, BAN, JAN)
  • AC 2993 LAR (IS: Amylin)
  • AC002993 (IS: Amylin)
  • AC2993 (IS: Amylin)
  • AC-2993 (IS: Amylin)
  • AC2993A (IS: Amylin)
  • Exendin-4 (IS: Heloderma suspectum)
  • Exendin-4 (IS: synthetic)
  • LY2148568 (IS: Amylin)
  • Medisorb (IS)

Brand Names

  • Baietta
    Eli Lilly, Mexico
  • Bydureon
    Amylin Pharmaceuticals, United States; AstraZeneca, Belgium; AstraZeneca, Switzerland; AstraZeneca, Germany; AstraZeneca, Finland; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Ireland; AstraZeneca, Israel; AstraZeneca, Italy; AstraZeneca, Latvia; AstraZeneca, Sweden; AstraZeneca AB, Cyprus; AstraZeneca UK, United Kingdom; Bristol Myers Squibb, Spain; Bristol-Myers Squibb/AstraZeneca, Austria; Eli Lilly Nederland, Hungary; AstraZeneca, France; AstraZeneca, Japan; AstraZeneca, Norway; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, Poland; Eli Lilly, Lithuania
  • Byetta
    Amylin Pharmaceuticals, United States; AstraZeneca, Belgium; AstraZeneca, Canada; AstraZeneca, Switzerland; AstraZeneca, Chile; AstraZeneca, Finland; AstraZeneca, France; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Ireland; AstraZeneca, Israel; AstraZeneca, Iceland; AstraZeneca, Japan; AstraZeneca, Norway; AstraZeneca, New Zealand; AstraZeneca, Sweden; AstraZeneca AB, Cyprus; AstraZeneca Singapore, Singapore; AstraZeneca UK, United Kingdom; Baxter, China; Baxter, Philippines; Bristol Myers Squibb, Spain; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb/AstraZeneca, Austria; Eli Lilly, Argentina; Eli Lilly, Australia; Eli Lilly, Hong Kong; Eli Lilly, Lithuania; Eli Lilly, Latvia; Eli Lilly, Poland; Eli Lilly Interamerica, Ecuador; Eli Lilly Nederland, Hungary; Eli Lilly Nederland BV, Greece; Lilly, Czech Republic; Lilly, Egypt; Lilly, Italy; Lilly, Oman; Lilly, Peru; Lilly, Turkey; Lilly, Taiwan; Lilly, South Africa; Lilly Pharma, Macedonia
  • BYETTA
    AstraZeneca, Germany
  • Caelyx
    AstraZeneca AB, Cyprus

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide